Novo to pay up to $2.6 billion to China's Hengrui for rights to weight-loss pill

3 verified updates • corroborated by 1 independent source • tracked since September 29, 2026

🔵
02:31 AM 1 source: Reuters
Novo Nordisk to license experimental GLP-1 pill from China's Hengrui
🟡
05:01 AM 1 source: Reuters
Novo Nordisk to license GLP-1 drug from China's Hengrui in $2.6 billion deal
🟡
06:01 AM 1 source: Reuters
Novo to pay up to $2.6 billion to China's Hengrui for rights to weight-loss pill